Please select the option that best describes you:
When treating younger men with anal cancer do you consider dose to the prostate?
Given risk of secondary malignancies do you make an effort to avoid/spare the prostate or give any specific dose constraints when treating young men with anal or rectal cancers?
Answer from: Radiation Oncologist at Academic Institution
Given the proximity of the prostate to a typical anorectal target volume, it would be difficult to completely spare the prostate without increasing the risk of a marginal miss. I would not recommend compromising target coverage to spare the prostateClinical concerns about prostate dose could involve...
Sign in or Register to read more